(Q44442996)

3 December 2017

title

A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain (English)

1 reference

3 December 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

Anesthesiology and pain medicine

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

author name string

Lois J. Kehl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

Darryl T. Hamamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

Paul W. Wacnik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

Devin L. Croft

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

Blake D. Norsted

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

George L. Wilcox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

Donald A. Simone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749972

2 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://journals.lww.com/10.1016/S0304-3959(02)00450-5

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

1 reference

3 December 2017

volume

103

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

175-186

1 reference

Treatment outcome in a multidisciplinary cancer pain clinic.

3 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Pain, opioid use, and survival in hospitalized patients with advanced cancer

2 January 2024

2

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

A prospective multicenter assessment of the Edmonton staging system for cancer pain

2 January 2024

3

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain

2 January 2024

4

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Control of pain initiation by endogenous cannabinoids.

2 January 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

Cancer pain management

6

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The management of cancer pain

2 January 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Pain and its treatment in outpatients with metastatic cancer

2 January 2024

10

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts

2 January 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Antipsychotic-like profile of alstonine

2 January 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain

2 January 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

2 January 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

2 January 2024

16

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.

2 January 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

2 January 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells

2 January 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

2 January 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

2 January 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Catalepsy induced by intrastriatal injections of Δ9-THC and 11-OH-Δ9-THC in the rat

2 January 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

2 January 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

2 January 2024

25

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

2 January 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The experience of chronic nonmalignant pain

2 January 2024

29

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2

2 January 2024

30

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

Marijuana and immunity

32

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The effects of depression and chronic pain on psychosocial and physical functioning.

2 January 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cellular and neurochemical remodeling of the spinal cord in bone cancer pain

2 January 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

2 January 2024

35

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases

2 January 2024

36

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms

2 January 2024

37

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The pharmacological control of musculoskeletal pain

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

A new animal model for assessing mechanisms and management of muscle hyperalgesia

2 January 2024

39

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo

2 January 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action

2 January 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats

2 January 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

2 January 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement

2 January 2024

44

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

CB2 cannabinoid receptor-mediated peripheral antinociception

2 January 2024

46

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Two distinctive antinociceptive systems in rats with pathological pain.

2 January 2024

47

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction

2 January 2024

48

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections

2 January 2024

49

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

2 January 2024

50

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla.

2 January 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

2 January 2024

52

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation.

2 January 2024

54

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

2 January 2024

55

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

A rat model of bone cancer pain

2 January 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Predictive factors in advanced cancer pain treated only by analgesics

2 January 2024

57

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Molecular characterization of a peripheral receptor for cannabinoids

2 January 2024

58

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

2 January 2024

62

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid receptors and pain

2 January 2024

63

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Marihuana as a therapeutic agent for muscle spasm or spasticity

2 January 2024

65

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Breakthrough pain: characteristics and impact in patients with cancer pain.

2 January 2024

66

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

2 January 2024

67

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice

2 January 2024

68

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Antihyperalgesic effects of spinal cannabinoids

2 January 2024

69

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

2 January 2024

70

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Activational role of cannabinoids on movement

2 January 2024

71

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain

2 January 2024

72

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

A mouse model of neuropathic cancer pain

2 January 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

2 January 2024

74

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain

2 January 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cancer pain--a provoker of emotional, social and existential distress

2 January 2024

77

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses

2 January 2024

78

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

2 January 2024

79

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Dopaminergic and cholinergic interaction in cataleptic responses in mice

2 January 2024

80

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain

2 January 2024

81

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan.

2 January 2024

82

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice

2 January 2024

84

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.

2 January 2024

85

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception

2 January 2024

86

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

2 January 2024

87

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway

2 January 2024

88

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

Ethical guidelines for investigations of experimental pain in conscious animals

2 January 2024

89

1 reference

https://api.crossref.org/works/10.1016/S0304-3959(02)00450-5

2 January 2024

Identifiers

1 reference

3 December 2017

1 reference